In 1321N1 astrocytoma cells, heterotrimeric G-protein coupled receptors that activate phosphoinositide-specific phospholipase Cβ (PLCβ) isoforms via Gq, induced a prolonged activation of protein kinase B (PKB) after a short delay. For example, the effect of carbachol acting on M 3 muscarinic receptors is blocked by wortmannin, suggesting it is mediated via a phosphoinositide 3-kinase (PI 3-kinase). In support of this, carbachol increased PI 3-kinase activity in PI 3-kinase (p85) immunoprecipitates. (ii) Ca 2+ ionophores and thapsigargin stimulated PKB activity in a wortmanninsensitive manner whilst BAPTA blocked carbachol-stimulated PKB activity. (iii)
Summary:
In 1321N1 astrocytoma cells, heterotrimeric G-protein coupled receptors that activate phosphoinositide-specific phospholipase Cβ (PLCβ) isoforms via Gq, induced a prolonged activation of protein kinase B (PKB) after a short delay. For example, the effect of carbachol acting on M 3 muscarinic receptors is blocked by wortmannin, suggesting it is mediated via a phosphoinositide 3-kinase (PI 3-kinase). In support of this, carbachol increased PI 3-kinase activity in PI 3-kinase (p85) immunoprecipitates.
The pathway linking PLC-coupled receptors to PI 3-kinase was deduced to involve phosphoinositide hydrolysis and Ca 2+ dependent ErbB3 transactivation, but not protein kinase C (PKC), based on the following evidence. (i) Inhibition of carbachol stimulated PLC by pretreatment with the phorbol ester, PMA, concomitantly reduced PKB activity while stimulation of other PLC-coupled receptors also activated PKB.
(ii) Ca 2+ ionophores and thapsigargin stimulated PKB activity in a wortmanninsensitive manner whilst BAPTA blocked carbachol-stimulated PKB activity. (iii)
Introduction
Protein kinase B (PKB), also known as c-Akt or Rac-PK is a 60 KDa serine/threonine kinase which is the cellular homologue of the viral oncogene, v-Akt (1, 2, 3). PKB family members appear to be over-expressed in some human cancers including those of the breast, pancreas and ovaries (3, 4) . Much of the interest in PKB stems from the discovery that this kinase is rapidly activated in response to a wide variety of receptor tyrosine kinases (RTKs) and that such activation is prevented by strategies that inhibit or prevent the activation of phosphoinositide 3-kinases (PI 3-kinases; 2, 3, 5,6). PKB is now established as one of several direct targets of the lipid products of PI 3-kinases, phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) and PtdIns(3,4)P 2 (7, 9) The current model for activation of PKB via RTKs involves phosphorylation at Thr-308 in the activation loop of the catalytic domain and Ser-473 in the carboxyl-terminal tail (5) . The phosphorylation of both sites is required for maximum activation and requires an interaction between the amino-terminal pleckstrin homology (PH) domain of PKB with PtdIns(3,4,5)P 3 or PtdIns(3,4)P 2 (5, 10, 11) . Lipid binding results in translocation of PKB to membranes and induces a conformational change in PKB making it an efficient substrate for upstream kinase(s). Phosphorylation of Thr-308 is accomplished by phosphoinositide-dependent protein kinase 1 (PDK1) which possesses a C-terminal cell line SW-480 (12, 13) . Such responses are generally blocked by PI 3-kinase inhibitors (14, 15, 16) and have been proposed to involve direct regulation of PI 3-kinase γ by G-protein βγ-subunits (12, 14) , even though endogenous expression of this isoform is thought to be restricted to haemopoietic cells (6, 13) . Other studies have implicated the involvement of type IA PI3K through a variety of putative mechanisms including: (i) association with Ras (12); (ii) association with PKCε (13); (iii) direct interaction with Gβγ (17); (iv) transactivation of EGF receptors (18) . There is also at least one report of wortmannin-insensitive activation of PKB via Gs-coupled β-adrenergic receptors (19) .
There are currently few reports of Gq-coupled receptors stimulating PKB and/or PI 3-kinases (20, 21) and our previous work established that such receptors actually reduce PI 3-kinase activity stimulated by insulin in 1321N1 astrocytoma cells (22) . We were, therefore, surprised to observe substantial activation of PKB when these cells were exposed to the muscarinic cholinergic agonist, carbachol, which acts primarily on Gqcoupled M 3 receptors in this system (23) . We show here that PKB activation occurs downstream of PLC activity, does not require PKC but does involve calcium, ErbB3 transactivation and subsequently activation of a p85-associated PI 3-kinase. Cell Culture: 1321N1 cells were grown to confluence in 6-or 24-multiwell plates as described previously (22) . The supernatants from cell lysates were then either assayed directly as described below or frozen in liquid nitrogen and stored at -80 o C for later analysis.
Experimental Procedures

In vitro kinase assays:
PI 3-kinase: Cell lysates (~1mg protein) were mixed for >2hrs at 4 o C on a shaking platform with antibodies against IRS-1 or p85 each of which was pre-coupled to protein-G beads (10µl/sample). Immunoprecipitates were collected by brief centrifugation then washed and assayed for PI 3-kinase activity as described previously (25, 26) .
PKB assay:
The PKB isoforms (α,β and γ) were immunoprecipitated from cell lysates (~300mg protein) using the isoform specific antibodies and the immunoprecipitates were assayed as described previously (2, 27) except that assays were continued for 45 min at 30 o C.
SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblotting: SDS-PAGE
and western blotting were performed as described previously (26) . while PLC responses to the other stimuli vary both in initial magnitude and in the rate and extent of desensitization (22, 29, 31) . Indeed the comparative efficacy of carbachol and SFLLRN in activating PKB is particularly noteworthy as the initial (<30sec) PLC response to the latter is several fold greater than that elicited by the former ligand, but desensitizes extensively within 1-2min following agonist addition (22) during which phase neither carbachol nor SFLLRN activates PKB. This result implies that relatively persistent stimulation of PLC is required for this response.
However, the ability of thrombin receptors in 1321N1 cells to couple to G-proteins in addition to Gq (32, 33) may also be relevant in this regard. Figure 6A examines the role of PKC in carbachol-stimulated PKB activity. Treatment of 1321N1 cells with the phorbol ester, PMA, on its own, failed to stimulate PKB. Consistent with this observation pre-treatment with the bisindolylmaleimide PKC inhibitor, Ro-318220, did not block carbachol-stimulated PKB (Fig 6A) . On the contrary, Ro-318220 enhanced both basal and carbachol-stimulated PKB activity, suggesting that either PKC or another Ro-318220-sensitive target exerts a tonic inhibitory influence on PKB activity in these cells. in Figure 6A show that carbachol-induced PKB activity was diminished in cells loaded with BAPTA-AM. As the PLC response to carbachol was not similarly affected by the chelator (not shown), these data clearly imply that the muscarinic receptor-mediated stimulation of PKB is dependent upon an increase in intracellular Ca 2+ distal to PLC activation. We would note, however, that while BAPTA/AM always attenuated carbachol-stimulated PKB activity, its inhibitory effect was considerably reduced when presented to cells in culture medium containing serium. By contrast, we found that another member of the erbB family, ErbB3, is tyrosine phosphorylated in response to both carbachol and EGF (Fig7B). The phosphorylation and activation of ErbB3 is known to generate a docking site for the SH2 domain of PI 3-kinase (42) . As shown in Fig7B, the association of PI 3-kinase with ErbB3 increased significantly following stimulation with either carbachol or EGF, and the tyrosine phosphorylation of ErbB3 increased in a time dependent manner, with a lag phase of 2 min, and reached maximum phosphorylation at ~ 15min. AG1478 inhibited both ErbB3 tyrosine phosphorylation and PKB activation (Fig 8A and B) . Taken together by guest on October 1, 2017
http://www.jbc.org/ Downloaded from these data suggest that ErbB3 transactivation is required for activation of PKB by carbachol.
Discussion:
We have investigated the signalling pathway linking endogenous muscarinic cholinergic receptors to the activation of PKB in 1321N1 astrocytoma cells. The evidence implicates PLC-mediated phosphoinositide hydrolysis, Ca 2+ , ErbB3 and the lipid products of PI 3-kinase as minimal components of the pathway. This is the first report directly demonstrating a link between a PLC-dependent signalling cascade and the activation of PKB, though other very recent studies have implied a similar conclusion (21) .
There have been several recent reports of GPCR-mediated activation of PKB. The majority of these responses involved pertussis toxin-sensitive G-proteins and were inhibited by wortmannin suggesting a requirement for PI 3-kinase activity (12, 14, 15, 16) . Relatively direct activation of the G-protein βγ-subunit sensitive PI 3-kinase γ and p110β isoforms have been suggested to account for some of these observations (12, 17) , but evidence also exists for indirect mechanisms involving Ras (15) and transactivation of EGF receptors (18) . By contrast, there is only one report of wortmannin-insensitive activation of PKB which was observed in β-adrenergic receptor-stimulated rat epididymal fat cells (19) .
The involvement of PI 3-kinase lipid products in carbachol-stimulated PKB activation is indicated by the marked sensitivity of the response to wortmannin, by the detection of PKB Ser473 and Thr308 phosphorylation, by the enhanced PI 3-kinase activity of p85 immunoprecipitates and by the small, but detectable increase in PtdIns(3,4,5)P 3 concentration. It remains possible, however, that the effect of PI 3-kinase inhibitors in this report may be mediated by reduction of the basal level of 3-phosphoinositides rather than by blockade of carbachol-induced PI 3-kinase activation. This seems unlikely because of the role of ErbB3 transactivation in carbachol-stimulated PKB activation and the inhibitory effect of AG1478, an EGF receptor tyrosine kinase inhibitor. The latter had no effect on basal PKB activity or PtdIns(3,4,5)P 3 levels (not shown).
The carbachol-stimulated response seems unlikely to be the result of a direct activation of PI 3-kinase by G-protein subunits. Firstly, evidence in the literature suggests that endogenous expression of the class IB PI 3-kinase, p110γ/p101 complex, is largely restricted to cells of haemopoietic lineage (6, 13 It has been reported that EGFR transactivation is a common element in GPCR signalling (40) . Carbachol, however, failed to stimulate a significant increase of EGFR tyrosine phosphorylation, although AG1478 blocked carbachol stimulated PKB. This may reflect limited expression of EGFR in 1321N1 cells, but our data suggest that Ca 2+ mediated PI 3-kinase activation involves an activation of ErbB3 and the subsequent recruitment of PI 3-kinase to the ErbB3 receptor. Since ErbB3 itself lacks intrinsic protein tyrosine kinase activity, it has been suggested that its phosphorylation occurs via heterodimerization with ErbB2 (47-49). The phosphorylation of ErbB2 has been reported in rat-1 cells stimulated by endothelin (ET-1), lysophosphatidic acid (LPA) and thrombin (40) .
So far the precise route from Ca 2+ to ErbB3 activation is unclear. One possibility could be the induction of secretion of EGF or other ligands for ErbB3 receptors compatible with the observed delay in the activation of PKB by carbachol. However, we were not able to detect activation of PKB using conditioned medium from cells pre-treated with carbachol, although this approach does not preclude release and action of EGF (or a similar ligand) in a tight autocrine loop. Recently it has been shown that EGF receptor transactivation by GPCRs involves proHB-EGF and a metalloproteinase activity that is rapidly induced upon GPCR-ligand interaction. The cleavage of the proHB-EGF by the metalloproteinase appeared to be essential for the GPCR-induced EGFR transactivation and downstream signalling (50) . It has also been reported that Src plays a role in GPCR transactivation of EGFR (51), but this seems unlikely to explain the activation of PKB we observed in PP1 (a potent Src inhibitor) pre-incubated cells (not shown).
In summary, our data describes a novel mechanism coupling PLC-dependent receptors to activation of PKB. The signalling pathway involves phosphoinositide hydrolysis and the resulting Ca 2+ signal which activates PI 3-kinase via ErbB3 transactivation. 
